Rapid aneuploidy testing, traditional karyotyping, or both?

Lancet

Volumn 366, Issue 9480, 2005, Pages 97-98

  Leung, W C ^a   Lao, T T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; DOWN SYNDROME; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; KARYOTYPING; MEDICAL ETHICS; NOTE; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; STRUCTURAL CHROMOSOME ABERRATION; X CHROMOSOME;

EID: 22244493861     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66791-8     Document Type: Note

References (15)

1. A Caine, AE Maltby, CA Parkin the UK Association of Clinical Cytogeneticists (ACC) Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment Lancet 2005 10.1016/S0140-6736(05)66790-6
2. MI Evans, GP Henry, WA Miller International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used Hum Reprod 14 1999 1213 1216
3. B Thilaganathan, S Sairam, T Ballard, C Peterson, R Meredith Effectiveness of prenatal chromosomal analysis using multicolour fluorescent in situ hybridization Br J Obstet Gynaecol 107 2000 262 266
4. AT Thein, SA Abdel-Fattah, PM Kyle, PW Soothill An assessment of the use of interphase FISH with chromosome specific probes as an alternative to cytogenetics in prenatal diagnosis Prenat Diagn 20 2000 275 280
5. P Lewin, P Kleinfinger, A Bazin, H Mossafa, S Szpiro-Tapia Defining the efficiency of fluorescence in situ hybridization on uncultured amniocytes on a retrospective cohort of 27 407 prenatal diagnoses Prenat Diagn 20 2000 1 6
6. RG Ryall, D Callen, R Cocciolone Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening Prenat Diagn 21 2001 553 557
7. WC Leung, D Chitayat, G Seaward Role of amniotic fluid interphase fluorescence in situ hybridization (FISH) analysis in patient management Prenat Diagn 21 2001 327 332
8. I Witters, K Devriendt, E Legius Rapid prenatal diagnosis of trisomy 21 in 5049 consecutive uncultured amniotic fluid samples by fluorescence in situ hybridization (FISH) Prenat Diagn 22 2002 29 33
9. WC Leung, ET Lau, TT Lao, MHY Tang Can amnio-polymerase chain reaction alone replace conventional cytogenetic study for women with positive biochemical screening for fetal Down syndrome? Obstet Gynecol 101 2003 856 861
10. J Homer, S Bhatt, B Huang, M Thangavelu Residual risk for cytogenetic abnormalities after prenatal diagnosis by interphase fluorescence in situ hybridization (FISH) Prenat Diagn 23 2003 566 571
11. GM Grimshaw, A Szczepura, M Hulten Evaluation of molecular tests for prenatal diagnosis of chromosomal abnormalities Health Technol Assess 7 2003 10
12. V Cirigliano, G Voglino, MP Canadas Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR: assessment on 18,000 consecutive clinical samples Mol Hum Reprod 10 2004 839 846
13. WC Leung, JJ Waters, L Chitty Prenatal diagnosis by rapid aneuploidy detection and karyotyping: a prospective study of the role of ultrasound in 1589 second-trimester amniocenteses Prenat Diagn 24 2004 790 795
14. D Warburton De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints Am J Hum Genet 49 1991 995 1013
15. C Donaghue, A Roberts, K Mann, CM Ogilvie Development and targeted application of a rapid QF-PCR test for sex chromosome imbalance Prenat Diagn 23 2003 201 210